Cargando…

Adverse drug reaction and causality assessment scales

Detalles Bibliográficos
Autor principal:	Zaki, Syed Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications 2011
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109846/ https://www.ncbi.nlm.nih.gov/pubmed/21712934 http://dx.doi.org/10.4103/0970-2113.80343

Ejemplares similares

Clinical causality assessment for adverse drug reactions
por: Parida, Satyen
Publicado: (2013)

Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions
por: Shukla, Ajay K., et al.
Publicado: (2021)

Causality Assessment of Cutaneous Adverse Drug Reactions
por: Son, Young-Min, et al.
Publicado: (2011)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Causality, Severity, and Avoidability of Adverse Drug Reactions in Hospitalized Children: A Prospective Cohort Study
por: Gupta, Saurabh, et al.
Publicado: (2023)

Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions()
por: Khan, Lateef M., et al.
Publicado: (2016)

Imputation of adverse drug reactions: Causality assessment in hospitals
por: Varallo, Fabiana Rossi, et al.
Publicado: (2017)

Acute multifocal dystonic reaction: An unusual presentation of vitamin D-deficient rickets
por: Zaki, Syed Ahmed, et al.
Publicado: (2011)

Adverse drug reaction monitoring in psychiatry out-patient
por: Tandon, Vishal
Publicado: (2012)

Adverse drug reactions in the era of multi-morbidity and polypharmacy
por: Birriel, T. Javier, et al.
Publicado: (2015)

Adverse drug reactions due to ophthalmic drugs: Reporting system in India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2016)

Causality assessment of adverse drug reaction in Pulmonology Department of a Tertiary Care Hospital
por: Khan, Amer, et al.
Publicado: (2015)

Causality or Relatedness Assessment in Adverse Drug Reaction and Its Relevance in Dermatology
por: Pande, Sushil
Publicado: (2018)

Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?
por: Manzo, Ciro
Publicado: (2021)

Incident Reporting of Adverse Drug Reaction to Intravenous Ranitidine in an Emergency Department
por: Sud, Saurabh, et al.
Publicado: (2018)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Adverse drug reactions with naltrexone: Experience from an addiction treatment center
por: Sarkar, Siddharth, et al.
Publicado: (2021)

Comment: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment
por: Danjuma, Mohammed, et al.
Publicado: (2020)

Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials
por: Ballow, Mark, et al.
Publicado: (2017)

System of adverse drug reactions reporting: What, where, how, and whom to report?
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2015)

Adverse reactions to nonsteroidal anti-inflammatory drugs and hypersensitivity to lipid transfer proteins
por: Nucera, Eleonora, et al.
Publicado: (2016)

Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education
por: Khan, Zakir, et al.
Publicado: (2020)

Adverse drug reactions of itolizumab in COVID-19 patient: A case report
por: Mohammed, Ziauddin, et al.
Publicado: (2022)

Clinical Profile and Comparison of Causality Assessment Tools in Cutaneous Adverse Drug Reactions
por: Beniwal, Ranjana, et al.
Publicado: (2019)

Discouraging adverse drug reactions reporting culture: Just a tip of the ‘Gullible Prescribing’
por: Mohammed, Imran
Publicado: (2013)

Proposal for Publishing and Parallel Reporting of Case Reports on Adverse Drug Reactions to Authorities by Physicians
por: Sickmüller, Barbara, et al.
Publicado: (2013)

Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection
por: Tang, Mi, et al.
Publicado: (2021)

Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection
por: Tang, Mi, et al.
Publicado: (2021)

Differences in reporting of adverse drug reactions due to COVID-19 vaccines depending on the reporter
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2023)

Tramadol-Related Adverse Drug Reactions at an Addiction Psychiatry Setting: A Cross-Sectional Analysis
por: Dhagudu, Naveen Kumar, et al.
Publicado: (2019)

Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19
por: Bakshi, Satvinder Singh, et al.
Publicado: (2021)

Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool
por: Gallagher, Ruairi M., et al.
Publicado: (2011)

Stamping a Case of Cutaneous Adverse Drug Reaction: Proving Beyond Causality Assessment
por: Das, Sudip, et al.
Publicado: (2018)

Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system
por: Mouton, Johannes P., et al.
Publicado: (2017)

Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
por: Jouanjus, Emilie, et al.
Publicado: (2019)

Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey
por: Khan, Zakir, et al.
Publicado: (2022)

Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database
por: Campillo, Jeremy T., et al.
Publicado: (2022)

Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020)

Increased Risk of Arrhythmia in COVID-19 Patients: Possible Roles of Both the Disease Pathophysiology and Adverse Drug Reactions
por: Rismanbaf, Ali
Publicado: (2020)

Oxcarbazepine-induced systemic lupus erythematosus: A rare and serious adverse drug reaction to a common anticonvulsant
por: Sinha, Anwita, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ma8vjg5u46iue8d6242fd1t6ev